Diagnostic performance of 68Ga-PSMA-11 PET/MRI-guided biopsy in patients with suspected prostate cancer: a prospective single-center study.
Daniela A FerraroAnton S BeckerBenedikt KranzbühlerIliana MebertAnka BaltenspergerKonstantinos G ZeimpekisHannes GrünigMichael MesserliNiels J RuppJan H RueschoffAshkan MortezaviOlivio F DonatiMarcelo T SapienzaDaniel EberliIrene Andrea BurgerPublished in: European journal of nuclear medicine and molecular imaging (2021)
This trial was retrospectively registered under the name "Positron Emission Tomography/Magnetic Resonance Imaging (PET/MRI) Guided Biopsy in Men with Elevated PSA" (NCT03187990) on 06/15/2017 ( https://clinicaltrials.gov/ct2/show/NCT03187990 ).
Keyphrases
- positron emission tomography
- pet ct
- contrast enhanced
- magnetic resonance imaging
- prostate cancer
- computed tomography
- pet imaging
- radical prostatectomy
- diffusion weighted imaging
- ultrasound guided
- fine needle aspiration
- magnetic resonance
- dual energy
- study protocol
- clinical trial
- image quality
- phase ii
- middle aged
- phase iii
- open label